Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata

NCT07749716 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Drug: VC005 tablets
DRUG: VC005 tablets
DRUG: VC005 placebo tablets

Sponsor

Jiangsu vcare pharmaceutical technology co., LTD